Pharming Group N.V. said its management will participate in two investor conferences in New York in September 2026. Chief Executive Officer Fabrice Chouraqui will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14 at 09:30 EDT/15:30 CEST. Pharming will also participate in Morgan Stanley’s 24th Annual Global Healthcare Conference on September 15. A live webcast and replay of the H.C. Wainwright presentation will be available through the Events and presentations and Our news sections of Pharming’s website. Headquartered in Leiden, the Netherlands, Pharming is a global biopharmaceutical company developing and commercializing small molecules and biologics for rare, debilitating and life-threatening diseases.